Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) FCF Margin (2022 - 2025)

Historic FCF Margin for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to 381.64%.

  • Centessa Pharmaceuticals' FCF Margin changed N/A to 381.64% in Q1 2025 from the same period last year, while for Sep 2025 it was 1206.96%, marking a year-over-year decrease of 62796100.0%. This contributed to the annual value of 2342.2% for FY2023, which is N/A changed from last year.
  • Per Centessa Pharmaceuticals' latest filing, its FCF Margin stood at 381.64% for Q1 2025.
  • In the past 5 years, Centessa Pharmaceuticals' FCF Margin registered a high of 3636.18% during Q2 2022, and its lowest value of 381.64% during Q1 2025.
  • For the 3-year period, Centessa Pharmaceuticals' FCF Margin averaged around 1948.32%, with its median value being 2034.55% (2022).
  • The largest annual percentage gain for Centessa Pharmaceuticals' FCF Margin in the last 5 years was -5613100bps (2023), contrasted with its biggest fall of -18373200bps (2023).
  • Over the past 3 years, Centessa Pharmaceuticals' FCF Margin (Quarter) stood at 2370.22% in 2022, then crashed by -49bps to 1209.26% in 2023, then crashed by -132bps to 381.64% in 2025.
  • Its FCF Margin was 381.64% in Q1 2025, compared to 1209.26% in Q4 2023 and 1473.24% in Q3 2023.